New Medicare drug price cap starts January 1, 2025, limiting out-of-pocket costs to $2,000 annually for beneficiaries under the Inflation Reduction Act.
Lawmakers focus on reforming the challenging prior authorization process as frustrations grow among health providers and patients in the insurance landscape.